Big companies seek innovation and efficiency
to meet the market demands that is always running in a high competitiveness
environment, meanwhile the start-ups with good ideas and solutions need to
ensure economic survival to bring their products to market.
In a global scenario, and with specific
knowledge of the brazilian market, brazilians start-ups gain notoriety not only
due to challenges such as risk taking in business, but also by bringing to
market the benefits of their innovative ideas. This business model has drawn
attention of big companies.
Start-ups do not have the strong, hard and
slow structures a big company has. The creative environment and people who can
generate new ideas make possible to make mistakes and try again fast and agile.
Typically, start-ups must focus on one idea
at a time; however, if that first idea is not as disruptive as first hoped, the
end of that idea could also be the end of the company. Those that do survive
often form the backbone of larger corporations’next-generation offerings,
through acquisition or licensing.
Despite the crucial role that start-ups play
in the medical technology industry, the current economic climate cannot be
overlooked. Continuing the trend of previous years, in the USA in 2011 we have
seen a decline in early stage investment in medical technology start-ups. The
investment that has been made has focused on start-ups whose technologies are
perceived to have a simpler regulatory pathway to market. The most complex
regulatory pathways are often associated with complex technology areas (for
example, in vivo imaging and surgical implants) and one could argue that it is
these areas that most need disruptive technologies.
For their part, the more progressive medical
corporations continue to recognize the importance of these smaller companies
(approximately 73% of the United States’ 5300 medical device companies had a
head-count of less than 20 in 2007) and many are taking a more collaborative
approach to fostering new technologies. Rather than buying an idea outright
before significant development has occurred, they are working with start-ups to
bring products closer to market through equity or resource investment.
That could be also a great way and
opportunity to develop the domestic brazilian medical device industry, that it,
working with start-ups to bring products closer to market through equity or
resource investment.
To read more about it, please, visit:
http://medtechinsider.com/archives/26930
